Genesis Pharmaceuticals Enterprises (江波制药) has begun marketing three TCM drugs from a portfolio of 22 recently acquired TCMs. Genesis bought the new products, all with SFDA approval, from Hongrui Pharma. The three drugs will be marketed under Genesis’ brand name, Jiangbo, and distributed through Genesis’ established network. Genesis expects the three products to produce $7.3 million of revenue in fiscal 2010. More details...

Stock Symbol: (OTCBB: GNPH)